Health Tip: Energy Drink Safety

-- While energy drinks are promoted as products that increase energy and enhance performance, they also can put users at risk. From 2007 to 2011, energy-drink related emergency room visits doubled. Overconsumption of energy drinks can cause a host of i

FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression

FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression March 5, 2019 -- The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of de

AHA News: Smoking Doubles Stroke Risk Among African-Americans

AHA News: Is Long-Distance Running Good for the Heart?

AHA News: Is Long-Distance Running Good for the Heart? FRIDAY, March 1, 2019 (American Heart Association News) -- As you can tell by all those 26.2-mile bumper stickers popping up around the country, the popularity of marathons and long-distance running

FDA Approves Herceptin Hylecta FDA Approves Herceptin Hylecta for Subcutaneous Injection in Certain HER2-Positive Breast Cancers

FDA Approves Herceptin Hylecta FDA Approves Herceptin Hylecta for Subcutaneous Injection in Certain HER2-Positive Breast Cancers South San Francisco, CA -- February 28, 2019 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today

FDA Approves Adhansia XR FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD

FDA Approves Adhansia XR FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD STAMFORD, Conn.--(BUSINESS WIRE) March 01, 2019 --Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announ